Growth of shareholder value in 319 newly-public biotech companies and paired controls, 1997-2016 (IMAGE)
Caption
Shareholder value at the end of 2016 compared to IPO for biotech companies and paired controls completing IPOs 1997-2016. Net growth in shareholder value, and the fraction of companies generating growth, were comparable for biotech and non-biotech companies.
Credit
Center for Integration of Science and Industry, Bentley University
Usage Restrictions
None
License
Licensed content